Coherus BioSciences: Q2 Earnings Snapshot

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Thursday reported a loss of $12.9 million in its second quarter.

On a per-share basis, the Redwood City, California-based company said it had a loss of 11 cents. Losses, adjusted for one-time gains and costs, were 14 cents per share.

The drug developer posted revenue of $65 million in the period, which beat Street forecasts. Four analysts surveyed by Zacks expected $57.1 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS